☆ 4.7 Article

Establishment and validation of nomograms to predict survival probability of advanced malignant pleural mesothelioma based on the SEER database and a Chinese medical institution

FRONTIERS IN ENDOCRINOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Construction and validation of a prognostic nomogram for anal squamous cell carcinoma

Ningning Yang et al.

Summary: A prognostic nomogram for predicting the survival probability of ASCC patients was established, incorporating four prognostic factors including age, sex, AJCC stage, and radiotherapy. The effectiveness and discrimination of the model were validated, and it showed higher predictive value compared to the AJCC stage. A risk stratification model was also constructed to divide patients into low-risk, medium-risk, and high-risk groups, demonstrating significant differences in overall survival.

CANCER MEDICINE (2022)

Add to Collection

Article Oncology

Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: A SEER database analysis

Sihao Chen et al.

Summary: This study developed a multivariate clinical prognostic model and a web-based survival risk calculator to accurately predict the survival of patients with malignant pleural mesothelioma (MPM). The model can assist clinicians in practicing individualized medicine.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Review Oncology

Immunotherapy in malignant pleural mesothelioma: a long story ended in success

Alberto Bongiovanni et al.

Summary: This review provides a comprehensive overview of the most promising immunotherapeutic-based strategies currently under investigation for advanced MPM.

JOURNAL OF CANCER METASTASIS AND TREATMENT (2022)

Add to Collection

Article Medicine, General & Internal

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Paul Baas et al.

Summary: Nivolumab plus ipilimumab demonstrated significant improvement in overall survival compared to standard chemotherapy for unresectable malignant pleural mesothelioma. This first-in-class treatment regimen has been approved for previously untreated patients in the USA and showed promising outcomes with manageable adverse events.

LANCET (2021)

Add to Collection

Article Oncology

Salvage radiotherapy for oligo-progressive malignant pleural mesothelioma

Paolo Ghirardelli et al.

Summary: This study investigated the efficacy and safety of focal radiotherapy for patients with oligo-progressive malignant pleural mesothelioma. The results showed that FRT was feasible in delaying further systemic therapies while maintaining local control, and it was more effective when performed after one line of systemic therapy.

LUNG CANCER (2021)

Add to Collection

Article Oncology

Development and validation of a novel nomogram to predict cancer-specific survival in patients with uterine cervical adenocarcinoma

Xiao Ni et al.

Summary: A prognostic nomogram for predicting cancer-specific survival in patients with uterine cervical adenocarcinoma was developed and validated, showing good accuracy and discriminative ability. The nomogram can help clinicians quantify the risk of mortality and make personalized survival assessments for optimal treatment plans for UAC patients.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Review Oncology

Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges

Kaushal Parikh et al.

Summary: Malignant pleural mesothelioma is a rare and aggressive thoracic malignancy with poor prognosis, but the recent approval of immune checkpoint inhibitors has brought hope for treatment. However, there are still unresolved challenges, such as determining the best upfront immune approach and utilizing predictive biomarkers.

CANCER TREATMENT REVIEWS (2021)

Add to Collection

Article Oncology

Development and validation of prognostic nomogram in ependymoma: A retrospective analysis of the SEER database

Zetian Jia et al.

Summary: A prognostic model was established using clinical data from the SEER database for patients with EPN, showing moderate discriminative ability in predicting 5 and 10-year survival probabilities. The nomograms developed may assist clinicians in personalized medicine for EPN patients.

CANCER MEDICINE (2021)

Add to Collection

Article Oncology

Addition of radiotherapy to surgery and chemotherapy improves survival in localized malignant pleural mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) study

Andrew B. Thompson et al.

LUNG CANCER (2020)

Add to Collection

Article Multidisciplinary Sciences

Development and validation of a nomogram for predicting late-onset sepsis in preterm infants on the basis of thyroid function and other risk factors: Mixed retrospective and prospective cohort study

Yuejun Huang et al.

JOURNAL OF ADVANCED RESEARCH (2020)

Add to Collection

Review Oncology

Clinical significance of histologic subtyping of malignant pleural mesothelioma

Luka Brcic et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2020)

Add to Collection

Article Oncology

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

Michele Carbone et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Add to Collection

Review Oncology

Pain management in patients with malignant mesothelioma: challenges and solutions

J. Saunders et al.

LUNG CANCER-TARGETS AND THERAPY (2019)

Add to Collection

Article Oncology

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer

Zhongxing Liao et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Review Oncology

Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review

Lisa Brusselmans et al.

TRANSLATIONAL LUNG CANCER RESEARCH (2018)

Add to Collection

Article Oncology

Characterizing CD137 upregulation on NK cells in patients receiving monoclonal antibody therapy

A. Makkouk et al.

ANNALS OF ONCOLOGY (2017)

Add to Collection

Article Oncology

Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas

Felipe Nor et al.

CLINICAL CANCER RESEARCH (2017)

Add to Collection

Article Oncology

Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma

Fauzia Shaikh et al.

JOURNAL OF THORACIC ONCOLOGY (2017)

Add to Collection

Review Oncology

Radiotherapy for the treatment of malignant pleural mesothelioma

Marc de Perrot et al.

LANCET ONCOLOGY (2017)

Add to Collection

Article Oncology

Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases

Ahmad S. Alfaar et al.

CANCER MEDICINE (2017)

Add to Collection

Article Oncology

A nomogram predicting pulmonary metastasis of hepatocellular carcinoma following partial hepatectomy

J. Li et al.

BRITISH JOURNAL OF CANCER (2014)

Add to Collection

Article Oncology

Current Issues in Malignant Pleural Mesothelioma Evaluation and Management

Jing Ai et al.

ONCOLOGIST (2014)

Add to Collection

Article Respiratory System

Malignant mesothelioma 2008

Michael D. Zervos et al.

CURRENT OPINION IN PULMONARY MEDICINE (2008)

Add to Collection

Article Oncology

Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma

GL Ceresoli et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)

Add to Collection

Article Oncology

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

NJ Vogelzang et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.